Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Torkildsen GL"'
Publikováno v:
Clinical Ophthalmology, Vol Volume 12, Pp 2617-2628 (2018)
Edward J Meier,1 Gail L Torkildsen,2 Paul J Gomes,3 Mark C Jasek4 1Apex Eye, Mason, OH, USA; 2Andover Eye, Andover, MA, USA; 3Allergy, Ora, Inc., Andover, MA, USA; 4Eyevance Pharmaceuticals, TX, USA Purpose: The purpose of these Phase III studies was
Externí odkaz:
https://doaj.org/article/dd456f467fde4c778cdab3f61ac7aca1
Publikováno v:
Clinical Ophthalmology, Vol 2016, Iss Issue 1, Pp 887-895 (2016)
Karl G Stonecipher,1,2 Gail L Torkildsen,3 George W Ousler III,4 Scot Morris,5 Linda Villanueva,6 David A Hollander6 1Department of Ophthalmology, University of North Carolina, Chapel Hill, 2TLC Laser Eye Centers, Greensboro, NC, 3Andover Eye Associa
Externí odkaz:
https://doaj.org/article/445c58ddf898415f96ad1bede45d0cea
Autor:
Williams JI, Kennedy KS, Gow JA, Torkildsen GL, Abelson MB, Gomes PJ, McNamara For The Bepotastine Besilate Ophthalmic Solutions Study Group TR
Publikováno v:
Journal of Ocular Pharmacology & Therapeutics; Aug2011, Vol. 27 Issue 4, p385-393, 9p
Autor:
Abelson MB (AUTHOR), Torkildsen GL (AUTHOR), Williams JI (AUTHOR), Gow JA (AUTHOR), Gomes PJ (AUTHOR), McNamara TR (AUTHOR), Bepotastine Besilate Ophthalmic Solutions Clinical Study Group (CORPORATE AUTHOR)
Publikováno v:
Clinical Therapeutics. Sep2009, Vol. 31 Issue 9, p1908-1921. 14p.
Publikováno v:
Clinical Therapeutics. Jul2008, Vol. 30 Issue 7, p1264-1271. 8p.
Publikováno v:
Clinical Therapeutics. Jul2008, Vol. 30 Issue 7, p1272-1282. 11p.
Autor:
Semba CP (AUTHOR), Torkildsen GL (AUTHOR), Lonsdale JD (AUTHOR), McLaurin EB (AUTHOR), Geffin JA (AUTHOR), Mundorf TK (AUTHOR), Kennedy KS (AUTHOR), Ousler GW (AUTHOR)
Publikováno v:
American Journal of Ophthalmology. Jun2012, Vol. 153 Issue 6, p1050-1060.e1. 1p.
Autor:
Wirta D; Eye Research Foundation, Newport Beach, CA., Torkildsen GL; Andover Eye Associates, Andover, MA., Boehmer B; Midwest Cornea Associates, LLC, Indianapolis, IN., Hollander DA; Ora, Inc, Andover, MA., Bendert E; Statistics Collaborative, Inc, Washington, DC; and., Zeng L; Statistics Collaborative, Inc, Washington, DC; and., Ackermann M; Oyster Point Pharma, Inc, Princeton, NJ., Nau J; Oyster Point Pharma, Inc, Princeton, NJ.
Publikováno v:
Cornea [Cornea] 2022 Oct 01; Vol. 41 (10), pp. 1207-1216. Date of Electronic Publication: 2021 Dec 21.
Autor:
Torkildsen GL; Andover Eye Associates, Andover, Massachusetts., Pattar GR; Eye Care Institute, Louisville, Kentucky., Jerkins G; Nashville Vision Associates, Nashville, Tennessee., Striffler K; Oyster Point Pharma Inc, Princeton, New Jersey., Nau J; Oyster Point Pharma Inc, Princeton, New Jersey. Electronic address: jnau@oysterpointrx.com.
Publikováno v:
Clinical therapeutics [Clin Ther] 2022 Sep; Vol. 44 (9), pp. 1178-1186. Date of Electronic Publication: 2022 Aug 11.
Autor:
Pattar GR; The Eye Care Institute, Louisville, KY, USA. Electronic address: drpattar@eyecareinstitute.com., Jerkins G; Advancing Vision Research LLC, Nashville, TN, USA., Evans DG; Total Eye Care, P.A., Memphis, TN, USA., Torkildsen GL; Andover Eye Associates, Inc, Andover, MA, USA., Ousler GW; Ora Inc., Andover, MA, USA., Hollander DA; Ora Inc., Andover, MA, USA., Holdbrook M; Allergan plc, Pleasanton, CA, USA., Senchyna M; Allergan plc, Irvine, CA, USA.
Publikováno v:
The ocular surface [Ocul Surf] 2020 Apr; Vol. 18 (2), pp. 249-257. Date of Electronic Publication: 2019 Sep 19.